• PDF / 168,950 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 77 Downloads / 140 Views

DOWNLOAD

REPORT

---

1 S

Colitis: case report In a dual-centre, observational, retrospective cohort study of 1074 patients conducted between January 2012 to October 2018, a patient [age and sex not stated] was described, who developed colitis during treatment with ipilimumab and nivolumab for cancer [routes and dosages not stated]. Subsequently, the patient developed colitis associated with ipilimumab and nivolumab [durations of treatments to reaction onset not stated]. Thereafter, the patient was admitted and had undergone a colectomy [outcome not stated]. Cheung VTF, et al. Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?. British Journal of Cancer 123: 207-215, No. 2, 21 803497778 Jul 2020. Available from: URL: http://doi.org/10.1038/s41416-020-0882-y

0114-9954/20/1818-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 22 Aug 2020 No. 1818